Vascular closure devices are an option for antegrade access but carry a higher rate of complications highlighting the need for careful patient and device selection

Vascular closure devices (VCDs) were introduced in the 1990s to reduce the time to hemostasis and enable early ambulation.1 Since that time, there has been a proliferation of devices, which now number ≥15.2 Along with the growth of technology, the rate of VCD usage has increased, demonstrated by their use in>75% of elective coronary cases in the Veterans Affairs Medical Centers.3 The increased use of VCDs has led to their use outside of the instructions for use, as illustrated in a recent report using data from the Vascular Quality Initiative.

Source: Journal of Vascular Surgery - January 20, 2021 Category: Surgery Authors: Justin Hurie Tags: Invited commentary Source Type: research